Redefining the Viral Reservoirs that Prevent HIV-1 Eradication

被引:378
作者
Eisele, Evelyn [1 ,2 ]
Siliciano, Robert F. [1 ,2 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; COMBINATION ANTIRETROVIRAL THERAPY; LOW-LEVEL VIREMIA; IN-VIVO; LATENT RESERVOIR; RESIDUAL HIV-1; INTRINSIC STABILITY; ONGOING REPLICATION; CHEMOKINE RECEPTOR;
D O I
10.1016/j.immuni.2012.08.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This Perspective proposes definitions for key terms in the field of HIV-1 latency and eradication. In the context of eradication, a reservoir is a cell type that allows persistence of replication-competent HIV-1 on a timescale of years in patients on optimal antiretroviral therapy. Reservoirs act as a barrier to eradication in the patient population in which cure attempts will likely be made. Halting viral replication is essential to eradication, and definitions and criteria for assessing whether this goal has been achieved are proposed. The cell types that may serve as reservoirs for HIV-1 are discussed. Currently, only latently infected resting CD4(+) T cells fit the proposed definition of a reservoir, and more evidence is necessary to demonstrate that other cell types, including hematopoietic stem cells and macrophages, fit this definition. Further research is urgently required on potential reservoirs in the gut-associated lymphoid tissue and the central nervous system.
引用
收藏
页码:377 / 388
页数:12
相关论文
共 139 条
[91]  
Perng Guey-Chuen, 2010, Interdiscip Perspect Infect Dis, V2010, P262415, DOI 10.1155/2010/262415
[92]   Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads [J].
Persaud, D ;
Siberry, GK ;
Ahonkhai, A ;
Kajdas, J ;
Monie, D ;
Hutton, N ;
Watson, DC ;
Quinn, TC ;
Ray, SC ;
Siliciano, RF .
JOURNAL OF VIROLOGY, 2004, 78 (02) :968-979
[93]   A stable latent reservoir for HIV-1 in resting CD4+ T lymphocytes in infected children [J].
Persaud, D ;
Pierson, T ;
Ruff, C ;
Finzi, D ;
Chadwick, KR ;
Margolick, JB ;
Ruff, A ;
Hutton, N ;
Ray, S ;
Siliciano, RF .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07) :995-1003
[94]   Controlling the elongation phase of transcription with P-TEFb [J].
Peterlin, B. Matija ;
Price, David H. .
MOLECULAR CELL, 2006, 23 (03) :297-305
[95]   HIGH-LEVELS OF HIV-1 IN PLASMA DURING ALL STAGES OF INFECTION DETERMINED BY COMPETITIVE PCR [J].
PIATAK, M ;
SAAG, MS ;
YANG, LC ;
CLARK, SJ ;
KAPPES, JC ;
LUK, KC ;
HAHN, BH ;
SHAW, GM ;
LIFSON, JD .
SCIENCE, 1993, 259 (5102) :1749-1754
[96]   Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1 [J].
Pierson, T ;
Hoffman, TL ;
Blankson, J ;
Finzi, D ;
Chadwick, K ;
Margolick, JB ;
Buck, C ;
Siliciano, JD ;
Doms, RW ;
Siliciano, RF .
JOURNAL OF VIROLOGY, 2000, 74 (17) :7824-7833
[97]   Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection [J].
Pierson, TC ;
Zhou, Y ;
Kieffer, TL ;
Ruff, CT ;
Buck, C ;
Siliciano, RF .
JOURNAL OF VIROLOGY, 2002, 76 (17) :8518-8531
[98]   Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication [J].
Pierson, TC ;
Kieffer, TL ;
Ruff, CT ;
Buck, C ;
Gange, SJ ;
Siliciano, RF .
JOURNAL OF VIROLOGY, 2002, 76 (08) :4138-4144
[99]   Antiretroviral therapy and central nervous system HIV type 1 infection [J].
Price, Richard W. ;
Spudich, Serena .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 :S294-S306
[100]   Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis [J].
Ramratnam, B ;
Bonhoeffer, S ;
Binley, J ;
Hurley, A ;
Zhang, LQ ;
Mittler, JE ;
Markowitz, M ;
Moore, JP ;
Perelson, AS ;
Ho, DD .
LANCET, 1999, 354 (9192) :1782-1785